Perceived Barriers to Pregnancy Vaccination Plans in Chile: A Qualitative Analysis

Perceived Barriers to Pregnancy Vaccination Plans in Chile: A Qualitative Analysis | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Perceived Barriers to Pregnancy Vaccination Plans in Chile: A Qualitative Analysis Báltica Cabieses, Alexandra Obach, Paula Madrid, Michelle Salder, and 3 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7871693/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 9 You are reading this latest preprint version Abstract Background Vaccination is widely recognized as a cost-effective public health intervention. However, vaccination rates among pregnant women have been decreasing, especially in low and middle-income countries and in subgroups like migrant communities. Hence, the purpose of this study was to unveil experiences, barriers and facilitators to vaccination recommended by Chile’s National Immunization Program among pregnant women, both locals and international migrants, in three large cities in Chile. Methods A multiple Case Study was conducted. Through snowballing technique, local and migrant pregnant women or women with toddlers (i.e., recently pregnant) were invited to participate (n = 28, 14 Chileans and 14 international migrants). Semi-structured interviews were held online based on a pre-defined guide and lasted for 60–90 minutes. Interviews were audio recorded and transcribed verbatim and analyzed thematically. The project was approved by the Scientific Ethics Committee at UDD. Results There was general consensus that the country has a very strong immunization program, along with a well-established vaccination culture and compliance with the national immunization plan. Participants identified five main barriers to access vaccines: (i) problems related to vaccine information, (ii) barriers related to potential adverse effects, (iii) some cases of disrespectful or neglectful treatment, (iv) social vulnerability and lack of social support, and (v) unique barriers faced by migrant women. Perceived facilitators were the following three: (i) timely and comprehensive access to information, (ii) free provision of vaccines, and (iii) preferential care at health centers. Conclusions Findings highlight the need for strengthening access to quality and timely information about the vaccination plan during pregnancy, improving client-provider communication, ensuring dignified treatment, and training healthcare workers about health rights of migrant pregnant women in the country. Addressing these multifaceted barriers requires integrated strategies that combine culturally sensitive education, improved provider-patient interactions, and systemic reforms to ensure equitable, non-discriminatory access to maternal vaccines. Vaccination Pregnant Women Emigrants and immigrants Qualitative Research Chile Health Care Quality Access and Evaluation CONTRIBUTION TO THE LITERATURE There is a paucity of qualitative research exploring the experiences and perceptions surrounding maternal vaccination in settings characterized by high immunization coverage and publicly funded vaccination programs, particularly within Latin American contexts such as Chile. This study offers novel empirical insights from Chile, elucidating the ways in which structural, relational, and cultural determinants shape decision-making processes regarding vaccination during pregnancy. The findings underscore the impact of immigration status and experiences of discrimination on both access to and trust in immunization services—an area that remains insufficiently examined in countries with well-established national vaccination programs. These results contribute to the global discourse by emphasizing the imperative for culturally responsive and rights-based approaches to ensure equitable access to maternal vaccination. The findings enhance the global understanding of the necessity for culturally sensitive and rights-centred strategies to promote equitable vaccination for pregnant women. BACKGROUND Vaccination is widely recognized as one of the most cost-effective public health interventions. It plays a crucial role in reducing mortality and morbidity across the lifespan and in preventing and controlling outbreaks of infectious diseases ( 1 ). Between 2010 and 2015, it is estimated that immunization efforts helped prevent over 5 million deaths annually ( 2 ). In 2012, the World Health Organization (WHO) launched the Global Vaccine Action Plan with the aim of achieving and sustaining high and equitable vaccination coverage worldwide. Despite these efforts, significant disparities in vaccine access and coverage persist between high-income countries and those with middle and low incomes, as well as within these countries themselves. These inequities continue to pose a major challenge to global public health ( 3 ). Strengthening immunization systems is essential for achieving the Sustainable Development Goals (SDGs) ( 4 ). In the aftermath of the pandemic, two major types of gaps in vaccination coverage have emerged. First, access to and use of SARS-CoV-2 vaccines has been highly unequal. Alarmingly, in 2022 only 11% of the total population in low-income countries received the COVID-19 vaccine ( 5 , 6 ). Second, the pandemic disrupted routine immunization efforts for other infectious diseases. Global coverage of national immunization programs declined from 86% in 2019 to 83% in 2020, the lowest number since 2009 ( 7 ). The regions most affected by these vaccination gaps include North Africa and the Middle East, South Asia, and Latin America and the Caribbean ( 8 ). There is the urgent need to understand the modifiable factors and mechanisms underlying vaccine inequalities, in addition to systemic challenges related to public policy, coordination, and health systems capacity to deliver vaccines ( 9 ). Other barriers have been identified—particularly the lack of trust in vaccines among socially vulnerable populations ( 10 ). Vaccine hesitancy is driven by a range of factors, including misinformation, perceived risks of adverse effects ( 2 ), and ideological opposition to vaccination ( 10 ). These concerns are often amplified in communities facing social exclusion, economic hardship, or historical marginalization ( 11 ). A sustained focus on health equity, national government commitment to immunization goals, affordable pricing, reliable supply chains, and targeted strategies to reach unvaccinated populations are all essential components of successful immunization programs ( 5 , 6 , 12 ). Vaccine hesitancy among pregnant women is a persistent global challenge that undermines maternal and neonatal health outcomes. Globally, pregnant individuals exhibit lower vaccine uptake compared to the general population, primarily due to concerns about vaccine safety, lack of clinical trial data, and mistrust in health systems( 13 ). A 2024 systematic review highlighted that misinformation—particularly via social media—has exacerbated fears about infertility, miscarriage, and congenital anomalies, especially in low- and middle-income countries ( 14 ). In Latin America, vaccine hesitancy is influenced by political instability, limited access to reliable health information, and historical distrust in public health institutions ( 15 ). Chile, a high-income country with mixed public and private health systems, has a strong National Immunization Plan that was created in 1938. Chile’s Programa Nacional de Inmunizaciones (PNI), established in 1978, is a central component of the country’s public health strategy, offering universal and free access to vaccines for all residents, regardless of migratory or socioeconomic status( 16 , 17 ). The program has achieved significant public health milestones, including the eradication of smallpox and poliomyelitis, and the control of diseases such as measles and diphtheria ( 16 , 17 ). One of the PNI’s key strengths lies in its high national coverage rates, supported by a robust logistical infrastructure and integration with maternal and child health services ( 18 ). The program is also characterized by strong institutional support and a clearly defined immunization schedule ( 16 , 17 ). Despite these strengths, the PNI faces several challenges, including inequities in access among migrant populations and residents of rural or underserved urban areas ( 19 ). Vaccine hesitancy has emerged as a barrier to maintaining high coverage, especially among pregnant women ( 19 ). Additionally, gaps in communication strategies have been reported, with some users citing inconsistent or insufficient information from healthcare providers ( 18 , 19 ). Although maternal vaccine coverage is higher than in many neighboring countries, hesitancy persists due to complacency, misinformation, and inconsistent recommendations from healthcare providers ( 20 ). A qualitative review of maternal vaccine uptake in low- and middle-income countries, including Chile, emphasized the importance of health system factors such as provider trust, policy clarity, and access to antenatal care ( 21 ). A 2024 global synthesis identified that strong provider recommendations, culturally sensitive communication, and convenient access to vaccines are key facilitators of maternal immunization ( 22 ). We observed an evidence gap in knowledge related to perceived barriers to accessing vaccination among pregnant women in Chile and; hence, this unique secondary analysis of a larger study aimed to unveil experiences, barriers and facilitators to vaccination recommended by Chile’s National Immunization Program among pregnant women. METHODS A multiple Case Study was conducted ( 23 ). This is a qualitative methodological design in which the researcher explores bounded systems through in-depth data collection. Case studies involve multiple sources of information to provide a detailed description of each case. We conducted this study in three large cities in Chile, Antofagasta (north of Chile, desertic climate with high density or migrant communities), Santiago (the largest city in the country, the capital, in the central area of the country, Mediterranean climate) and Osorno (south of Chile, marine west coast climate). The context of the study is detailed in the supplementary files. This secondary analysis if part of a larger study that aimed to understand vaccination hesitancy for multiple vaccination efforts deployed in the country, including COVID-19 and the national immunization plan strategy. Based on theoretical and practical grounds, as well as similar to previous international studies ( 24 , 25 ), the estimated initial sample size was 28. The study sample was constructed based on the priority groups defined by Chile’s National Immunization Program. We identified community leaders (n = 12) as sample seeds and from them we continued recruitment through snowballing technique. 58 pregnant women or women with toddlers (i.e., recently pregnant) were invited to participate in the study. Given the growing proportion of international migrants living in the country (around 12% of the total population ( 26 )), we also included migrant women in the sample recruitment process. Once the sample size was achieved (n = 28, 14 Chileans and 14 international migrants), recruitment stopped. Those who declined to participate cited lack of time or interest. Field work took place between 01 January 2023 and 30 April 2024. Semi-structured interviews were held online based on a pre-defined guide and lasted for 60–90 minutes. Table 1 describes the study´s sample. Semi-structured interview guide appears in supplementary files. Table 1 Description of study sample Pregnant Woman / Woman with toddlers (0–18 months) N % 28 100 City Antofagasta 9 32% Santiago 9 32% Osorno 10 36% Sex Female 28 100% Age 19–30 13 46% 31–40 13 46% 41–50 2 7% Nacionality chilean 14 50% migrant 14 50% Health System Public Health System 21 75% Private Health System 7 25% Interviews were audio recorded and transcribed verbatim into a Word document and subsequently analyzed thematically, following the guiding categories outlined in the interview script, while also allowing for the emergence of new categories based on participants’ narratives. Random revisions were conducted by a second research team member to over a third of transcriptions to secure quality. Selected quotes were translated to English for publication aims and double-checked by an independent team member who was fluent in academic English writing. To ensure the credibility and reliability of the study, the following rigor criteria were applied: (i) Participant triangulation: findings were triangulated across different study participants to enhance the robustness of the analysis. (ii) Reflexivity: the research team engaged in continuous discussion and reflection on preliminary findings as data collection progressed, in order to deepen thematic insights and enrich the analysis and presentation of results. Data saturation was achieved at 30 interviews for the dimensions of: general perception of the immunization plan, barriers and facilitators. This study was funded by the MSD Grant Global Health Equity Catalyst Fund. The project was approved by the Scientific Ethics Committee of the Faculty of Medicine Clinica Alemana, Universidad del Desarrollo (#2023-02). RESULTS General perceptions about the National Immunization Plan There was consensus among interviewees that the country has a very strong immunization program. It is noted that there is broad coverage, without restrictions, with a “wide set” of vaccines available, and that the vaccination process is easily accessible and free of charge. This is further supported by the perception that Chile has an established “vaccination culture” and that people are generally “compliant” with the national immunization plan. “I think it's easy to access vaccines in Chile. There's a super strict, controlled plan for which vaccines you should get throughout your life. And that information is readily available, and it's easy to access that vaccine” (Chilean Woman 14, Osorno, Public Health System). The vast majority expressed that Chile has a very strong immunization program in comparison to other countries. International migrants considered that Chile’s vaccination plan is significantly more comprehensive and accessible than those in their countries of origin and other Latin American countries. Interviewees particularly highlighted the limited availability of vaccines in their home countries, often in the context of overwhelmed health systems. “There [in Peru] almost no one has insurance, but here they do. Here they vaccinate everyone, whether Chilean or foreign, everyone, if they have to, even if you don't have a visa, even if you're illegal, it doesn't matter, we'll vaccinate you anyway, and that's good” (Migrant Woman 1, Antofagasta, Public Health System). It is mentioned that the vaccination plan has evolved: new vaccines have been incorporated or some older ones have been “updated,” and booster doses for certain diseases have been added or increased. As part of this “updating” of components, several people mention that current vaccines cause fewer skin reactions and leave less scarring than those administered a few decades ago. In addition to the integration of new vaccines (including the COVID-19 vaccine), the administration of vaccines considered “seasonal,” such as the influenza vaccine, is perceived to have been “intensified.” “I believe there are more vaccines, especially because there are more influenza vaccines, which are boosters, and also Covid vaccines, so there is more monitoring (…)” (Migrant Woman 5, Antofagasta, Public Health System). Perceptions of the vaccination plan in pregnant women Positive perceptions are identified, primarily stemming from trust in the effectiveness of vaccines and the belief that they provide protection against disease. The perceived importance of vaccination is often reinforced by personal experiences—or those of close acquaintances—with illnesses that are now preventable through immunization. Trust in vaccines is further supported by accounts of individuals close to the respondents who did not experience adverse effects following vaccination during pregnancy. “At no time was I afraid, let's say, about the vaccines, because I always did everything the gynecologist told me, the tests and everything, so I didn't feel like it was something that could put me or the baby at risk, because from the moment they told me it was a vaccine that I had to receive while I was pregnant, I said 'everyone does it, I mean, everyone, I'm not going to be the first,' and then talking to pregnant friends, of course, they were receiving them, they already had them and nothing had happened to them, so I was kind of calm about that” (Chilean Woman 1, Antofagasta, Private Health System). Individuals who exhibit a more passive adherence to vaccination generally perceive vaccination during pregnancy as a procedural requirement, rather than an emotionally significant experience. They tend not to associate the process with strong feelings. Conversely, those who express concerns about potential adverse effects of vaccines report experiencing fear. “I got vaccinated without thinking too much about it. What I do remember is that throughout the vaccination process during pregnancy, I felt a bit of fear. I wasn’t sufficiently informed to understand why I was getting vaccinated. The doctor didn’t guide me much through the process. And when I started to do my own research, it was like, ‘What am I doing?’ But I thought, ‘I have to do it,’ and I didn’t question it much. Still, I got vaccinated during pregnancy with a lot of fear” (Chilean Woman 13, Osorno, Public Health System). Among pregnant or recently pregnant women who identified themselves as adherent to vaccination, the vaccines most frequently mentioned were Influenza, COVID-19, and Tdap. Although the Tdap vaccine protects against diphtheria, tetanus, and pertussis, it is most commonly recalled simply as the “pertussis” or “whooping cough” vaccine. The vast majority of participants reported being unaware of the Tdap vaccine prior to pregnancy. It was primarily during prenatal care visits—both in public and private healthcare settings—that they learned about its existence and importance. “I mean, if the midwife hadn't told me, I think it was in a good way, just like last time, I would have never had any idea that I had to get vaccinated against whooping cough. No... I didn't even know that whooping cough existed.” (Migrant Woman 8, Santiago, Public Health System) Cases in which women reported not having been vaccinated during pregnancy correspond to those who initiated antenatal care late or were in transit between countries during their pregnancy. The vast majority mentioned public or private health centers or vaccination clinics, with one reference to mobile health campaigns in Antofagasta. Barriers, facilitators and recommendations for improvement Participants mentioned five types of barriers to accessing vaccination in Chile. First, they referred to problems related to vaccine information. The public health system is perceived as delivering incomplete information, with a sense that there is no interest in providing information. In contrast, the private healthcare system is generally trusted to provide all the necessary information. “If it's not through your gynecologist, I think that if... There is no other area, or there is no other channel that informs you that you have to get the vaccine (...) I have not seen other channels, other than, if it is a person who is interested and to look it up through the Ministry, or to look for the calendar, but I don't know if the entire population is very attentive to vaccines and when each person's turn comes” (Chilean Woman 5, Santiago, Private Health System). Second, barriers related to potential adverse effects were identified as a barrier to attending prenatal health check-ups. Third, some women reported negative experiences and reported some cases of disrespectful or neglectful treatment when attending to antenatal controls. “It has happened to me that they see you and everything is quick and then they weigh you, measure you and everything. It's like you feel vulnerable. Well, that's how I felt when I went to the doctor's office and I felt like that, like... I didn't like how they treated me. It's like they push you around... You know, we're people, but they don't see that... Because, yes, they have more education, they have studies, but they should be humbler. Especially with pregnant women, who are more, uh... prone to crying, we get more sentimental... But they don't care about that" (Chilean Woman 8, Santiago, Public Health System). The fourth perceived barrier to accessing vaccination plans are related to social vulnerability and lack of social support. Economic constraints were identified as a barrier to attending health check-ups, along with the lack of support networks for childcare and the inability to take time off work. The fifth and final barrier had to do with participants reporting unique barriers faced by migrant women in the country, mostly related to (i) lack of familiarity with the Chilean healthcare system, (ii) limited information about vaccines administered in the country of origin or during transit, (iii) delayed initiation of antenatal care, (iv) administrative barriers to accessing healthcare services, (v) experiences of discrimination and xenophobia, and (vi) transitions to the private healthcare system in search of respectful treatment “When I was pregnant, it depended on the person I was assigned to see whether I was treated. Sometimes they would see me, but other times I would get a person who would say no, ask for my papers, and put up a thousand obstacles to not accepting me while I was pregnant, feeling unwell (…)” (Migrant Woman 7, Santiago, Public Health System). Facilitators of vaccination access in Chile, as reported by participants, include timely and comprehensive access to information, free provision of vaccines, and preferential care at health centers. The availability of vaccines was particularly emphasized by women. Additional facilitators include workplace permissions and accommodations, with some participants affirming that “vaccination is a right.” For migrant women included in this study, universal access to healthcare—without the need for a provisional national ID number (RUT)—was highlighted as a key enabler of vaccination during pregnancy. "The speed, the attention, and the availability of vaccines. There are times when other places don't have them, but here I really can't complain, because during my pregnancy, all the vaccines were available. You arrive, get the number, and they'll see you immediately." (Migrant Woman 7, Santiago, Public Health System) “I arrived pregnant, I registered, and they already gave me my RUT number. But even before they gave me my RUT number, they had already seen me because it was due to the pregnancy (…)” (Migrant Woman 9, Santiago, Public Health System). Finally, three main recommendations appeared from participants: (i) to strengthen access to quality and timely information about the vaccination plan in Chile, especially during pregnancy, (ii) improve patient-provider interactions and communication and the way pregnant women are treated, and (ii) train healthcare workers about health rights of migrant pregnant women in the country, including translated information packs for this population residing in the country. "I think for pregnant women, more information, because I had no idea what I could access or what my health rights were. And for those of us who have breastfeeding children and are pregnant, I insist on having information in other languages, like Creole for Haitians" (Migrant Woman 8, Santiago, Public Health System). DISCUSSION Our study aimed to unravel experiences and perceptions from the perspective of pregnant women, both Chileans and international migrants, about vaccination schemes during pregnancy in Chile. Our findings suggest that there is an established vaccination culture and that people are generally compliant with the national immunization plan. We also found a number of perceived barriers and facilitators to accessing vaccines, which are from the provider and the demand sides, as well as the interaction between the two parts. Our findings are consistent with the international evidence. Low compliance with maternal vaccination schedules remains a significant public health concern both globally and in Latin America. Research indicates that vaccine hesitancy—often rooted in misinformation, fear of adverse effects, and concerns about fetal safety—is a primary barrier to uptake among pregnant women ( 27 , 28 ). These fears are frequently exacerbated by limited access to reliable health information, particularly in underserved populations such as migrants and rural communities ( 29 ). In Latin America, structural challenges including fragmented health systems, inconsistent communication from healthcare providers, and logistical barriers to accessing prenatal care further hinder vaccination adherence ( 30 ). Socioeconomic factors, such as unstable employment, lack of childcare support, and transportation difficulties, also contribute to missed opportunities for immunization ( 31 ). Addressing these multifaceted barriers requires integrated strategies that combine culturally sensitive education, improved provider-patient communication, and systemic reforms to ensure equitable access to maternal vaccines. This study contributes to existing public health research and policy. In Chile, qualitative research on vaccine hesitancy among pregnant women remains limited, despite growing global evidence highlighting the complexity of maternal decision-making regarding immunization ( 32 ). However, in the Chilean context, there is a notable gap in understanding how factors like migration status and regional disparities shape vaccine perceptions and behaviors during pregnancy ( 33 ). Addressing these gaps requires investment in locally grounded, interdisciplinary research that engages pregnant women as co-creators of knowledge and policy solutions. Policy implications of this study are related to the lack of culturally and contextually grounded research calls for the integration of participatory approaches in health policy design, ensuring that interventions reflect the lived experiences of diverse populations, including indigenous and migrant women ( 33 ). Also, policies should strengthen the role of primary care providers as trusted sources of vaccine information, supported by training in culturally sensitive communication and shared decision-making ( 34 ). This qualitative study offers valuable insights into the complex and context-specific factors influencing pregnant women's hesitancy toward vaccination, particularly by capturing personal narratives, cultural beliefs, and emotional responses that quantitative methods may overlook. Through in-depth interviews and thematic analyses, we could explore nuanced perceptions of risk and trust in healthcare systems ( 20 ). However, this study has a relatively small sample size, facing limitations in generalizability and may not adequately represent the diversity of experiences across different socioeconomic, ethnic, or geographic groups of pregnant women that reside in the three cities included in this study ( 35 ). Additionally, findings may be influenced by selection bias, as these women were recruited through snowballing technique. Despite these constraints, this qualitative study shed light on current understanding of vaccination perceptions and barriers among pregnant women in Chile, hence remaining essential for hypothesis generation and for informing culturally sensitive interventions, especially in under-researched populations ( 20 ). Moreover, this analysis fills a gap in the pressing need for qualitative research that incorporates the voice of pregnant women, especially among some marginalized groups such as migrants, who often face compounded barriers to vaccine access and acceptance ( 20 ). Future research should prioritize longitudinal designs, participatory methodologies, and culturally tailored interventions to better inform practice and policy. CONCLUSIONS This study demonstrates that, despite widespread recognition of Chile’s immunization program as robust and internationally acclaimed, a closer examination of maternal vaccination reveals persistent barriers and challenges in access. Although the national system offers broad coverage, free provision, and nominal accessibility, low adherence among pregnant women is primarily driven by structural and relational factors. These include insufficient and untimely information, concerns about adverse effects, inadequate interpersonal treatment within healthcare settings, and socioeconomic vulnerability. For migrant women, additional barriers emerge, such as limited knowledge of the healthcare system, administrative obstacles, experiences of discrimination, and delayed initiation of prenatal care. Nevertheless, the policy of universal access to vaccination—without requiring a tax identification number—serves as a significant facilitator. Our findings highlight the urgent need for structural reforms and integrated strategies aimed at enhancing information dissemination, strengthening communication between healthcare providers and users, and fostering culturally sensitive care. This research provides critical qualitative evidence to inform the development of more equitable and inclusive maternal vaccination policies. Abbreviations WHO World Health Organization SDGs Sustainable Development Goals PNI Chile´s National Immunization Plan Tdap Diphtheria, Tetanus, and Pertussis Vaccine Declarations Ethics approval and consent to participate This study was conducted in accordance with the appropriate guidelines and regulations for research involving human beings, including the Declaration of Helsinki. It received approval from the Scientific Ethics Committee at Universidad del Desarrollo (#2023-02) before its execution. All participants read and signed an online informed consent. Consent for publication Not applicable. Availability of data and materials The data supporting this study's findings are available on request from the corresponding author, A.O. However, the data are not publicly available due to participants confidentiality. Competing interests The authors declare that they have no competing interests. The entire study was conducted independently by the research team at UDD. Funding This study was funded by MSD Equity grant, which has applied to and granted by an external reviewing committee. Author contributions All authors contributed to the investigation, validation, visualization, and editing of the manuscript. Authors BC, AO, and AC were responsible for the conceptualization. Authors BC, AO, MS, and AB contributed to the methodology. Formal analysis was conducted by Authors BC, AO, and MS, while data curation was managed by Authors AO, PM, MS, and SB. Project administration was overseen by Authors BC, AO, PM, AC, and SB, with supervision provided by Authors BC, AO, AC, and SB. Funding acquisition and resource management were handled by Authors BC and AO, and the original draft was prepared by Authors BC, AO, and PM.I certify that this manuscript represents an original work and that it, or another work with substantially similar content by me, has not been published, in parts or completely, nor is it being considered for publication by another journal, be it in print or digital publications. Acknowledgements We acknowledge all study participants for their time and generosity. The final version of the manuscript went through final grammar revision and editing in Grammarly software. References World Health Assembly. Global vaccine action plan. Geneva; 2012. Patel MK, Goodson JL, Alexander JP, Kretsinger K, Sodha SV, Steulet C, et al. Progress Toward Regional Measles Elimination — Worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;69(45):1700–5. Gavi.The Vaccine Alliance. Immunisation and the Sustainable Development Goals. 2024. United Nations. Transforming our world: the 2030 Agenda for Sustainable Development [Internet]. New York. 2015. Available from: https://sdgs.un.org/publications/transforming-our-world-2030-agenda-sustainable-development-17981 World Health Organization. Strategy to Achieve Global Covid-19 Vaccination by mid-2022 [Internet], Washington DC. 2022. Available from: https://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf?sfvrsn=5a68433c_5 World Health Organization, Accelerating. COVID-19 Vaccine Deployment Removing obstacles to increase coverage levels and protect those at high risk [Internet]. Washington DC; 2022 Mar. Available from: https://www.who.int/publications/m/item/accelerating-covid-19-vaccine-deployment World Health Organization. Routine immunization services during the COVID-19 pandemic [Internet]. Geneva. 2020. Available from: https://apps.who.int/iris/handle/10665/331925 UNICEF. COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows [Internet]. Genova/ New York; 2021. Available from: https://www.unicef.org/press-releases/covid-19-pandemic-leads-major-backsliding-childhood-vaccinations-new-who-unicef-data#:~:text=GENEVA%2FNEW%20YORK%2C%2015%20July,today%20by%20WHO%20and%20UNICEF World Health Organization. Progress and challenges with achieving universal immunization coverage [Internet]. Genova. 2025. Available from: https://www.who.int/publications/m/item/progress-and-challenges Goje O, Kapoor A. Meeting the challenge of vaccine hesitancy. Cleve Clin J Med. 2024;91(9 suppl 1):S50–6. Kim Y, Iachan R, Boyle J, Deng Y. Association Between County-Level Social Vulnerability and Vaccine-Related Attitudes and Hesitancy Toward COVID-19 Vaccination in the United States. Vaccines (Basel). 2024;12(12):1368. UNICEF. Immunization Supply Chain Interventions to Enable Coverage and Equity in Urban Poor, Remote Rural and Conflict Settings [Internet]. New York. 2020. Available from: https://www.unicef.org/media/96611/file/Immunization%20supply%20chain%20interventions.pdf Casubhoy I, Kretz A, Tan HL, St Clair LA, Parish M, Golding H, et al. A scoping review of global COVID-19 vaccine hesitancy among pregnant persons. NPJ Vaccines. 2024;9(1):131. Kennedy SH, MacDonald NE, Costa Clemens SA. Vaccination in pregnancy. Front Glob Womens Health. 2025;5. Gonçalves BA, Matos CC, de Ferreira SA, Itagyba JV, Moço RF, Couto VR. MT. Hesitação vacinal contra a COVID-19 na América Latina e África: uma revisão de escopo. Cad Saude Publica. 2023;39(8). Departamento de vacunas e inmunizaciones. Ministerio de Salud de Chile. [cited 2025 Aug 7]. Vacunas. Available from: https://vacunas.minsal.cl/ Ministerio de Salud. ESTRATEGIA, NACIONAL DE SALUD PARA LOS OBJETIVOS, SANITARIOS AL 2030 [Internet]. 2022. Available from: https://www.fao.org/faolex/results/details/en/c/LEX-FAOC223969 OECD. OECD Reviews of Public Health: Chile [Internet]. OECD. 2019. Available from: https://www.oecd.org/content/dam/oecd/en/publications/reports/2019/01/oecd-reviews-of-public-health-chile_g1g9a372/9789264309593-en.pdf Alianza del Centro de Estudios Justicia y Sociedad de la Pontificia Universidad Católica de Chile, Fundación, Colunga W, Chile UNICEF, Chile. Estudio exploratorio de caracterización de niños, niñas y adolescentes migrantes de América Latina y el Caribe y sus familias en Chile [Internet]. Santiago; 2020 Oct. Available from: https://www.unicef.org/chile/media/4476/file/Informe.pdf Razai MS, Mansour R, Ravindran P, Freeman S, Mason-Apps C, Morris J, et al. Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review. PLoS ONE. 2024;19(4):e0298407. Davies B, Olivier J, Amponsah-Dacosta E. Health Systems Determinants of Delivery and Uptake of Maternal Vaccines in Low- and Middle-Income Countries: A Qualitative Systematic Review. Vaccines (Basel). 2023;11(4):869. Bhattacharya O, Siddiquea BN, Shetty A, Afroz A, Billah B. COVID-19 vaccine hesitancy among pregnant women: a systematic review and meta-analysis. BMJ Open. 2022;12(8):e061477. Yin RK. Case Study Research and Applications: Design and Methods. 6th ed. SAGE; 2017. Berendes S, Mounier-Jack S, Ojo-Aromokudu O, Ivory A, Tucker JD, Larson HJ, et al. Figuring stuff out myself – a qualitative study on maternal vaccination in socially and ethnically diverse areas in England. BMC Public Health. 2023;23(1):1408. Cox E, Sanchez M, Baxter C, Crary I, Every E, Munson J, et al. COVID-19 Vaccine Hesitancy among English-Speaking Pregnant Women Living in Rural Western United States. Vaccines (Basel). 2023;11(6):1108. Servicio Nacional de Migraciones (SERMIG). Gobierno de Chile. 2025 [cited 2025 Aug 7]. Estimaciones de extranjeros residentes en Chile al 31 de diciembre de 2024. Available from: https://serviciomigraciones.cl/estudios-migratorios/estimaciones-de-extranjeros/ Kilich E, Dada S, Francis MR, Tazare J, Chico RM, Paterson P, et al. Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis. PLoS ONE. 2020;15(7):e0234827. MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161–4. Rodriguez-Morales AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, Escalera-Antezana JP, Alvarado-Arnez LE, et al. Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama. Travel Med Infect Dis. 2025;65:102839. Pan American Health Organization. Maternal immunization in Latin America and the Caribbean: A review of current practices and challenges. Washington, DC; 2022. Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9. Razai MS, Ussher M, Goldsmith L, Hargreaves S, Oakeshott P. Navigating vaccination in pregnancy: Qualitative study in 21 ethnically diverse pregnant women. PLoS ONE. 2025;20(1):e0310823. Nuñez-Franz L, Rubilar P, Apablaza M, Canales L, Cortés LJ, Molina X, et al. Population-based seroprevalence survey: post-pandemic COVID-19 vaccination, related factors, and geographic distribution of vaccine acceptability in Chile. BMC Public Health. 2025;25(1):1176. Troncoso-Espinoza PV, Figueroa-Lassalle CF. Hacia una atención de calidad integral en las maternidades con perspectiva de derechos humanos. Rev Chil Obstet Ginecol. 2022;87(2). Mendez I, Gilliard VG, Randall LA, Robertson A. Attitudes and Experiences Regarding Communication About Maternal Vaccination: Qualitative Findings from Non-Hispanic Black Pregnant People. J Womens Health. 2025;34(1):1–7. Additional Declarations No competing interests reported. Supplementary Files SupplementaryfilesBMC.docx Cite Share Download PDF Status: Under Review Version 1 posted Editorial decision: Revision requested 15 Dec, 2025 Reviews received at journal 14 Dec, 2025 Reviews received at journal 27 Nov, 2025 Reviewers agreed at journal 26 Nov, 2025 Reviewers agreed at journal 19 Nov, 2025 Reviewers invited by journal 10 Nov, 2025 Editor assigned by journal 01 Nov, 2025 Submission checks completed at journal 01 Nov, 2025 First submitted to journal 15 Oct, 2025 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7871693","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":546503122,"identity":"918f678a-097c-4235-9753-650fecea4e58","order_by":0,"name":"Báltica Cabieses","email":"","orcid":"","institution":"Universidad del Desarrollo","correspondingAuthor":false,"prefix":"","firstName":"Báltica","middleName":"","lastName":"Cabieses","suffix":""},{"id":546503123,"identity":"b76c1e3e-4027-41de-b44a-7680394ad9e6","order_by":1,"name":"Alexandra Obach","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAoklEQVRIiWNgGAWjYFACHgYGxgYbBoYDCQwMD0jQkgbRkkCClsMkaOFv7z344eeO84l9xxMYPxClReLMuWTJ3jO3E2eeecAsQZzDbuQYSDO23U7ccCOBjTiHyd/IMf7N2HaOBC0GN3LMgLYcIEGL4ZlzaZa9bcnGM888bCbOL3LHew/f+NlmJ9t3PPnghw/EaEECjA0kahgFo2AUjIJRgBMAAJkZO1Aff4SsAAAAAElFTkSuQmCC","orcid":"","institution":"Universidad del Desarrollo","correspondingAuthor":true,"prefix":"","firstName":"Alexandra","middleName":"","lastName":"Obach","suffix":""},{"id":546503124,"identity":"f0367e5f-0c03-46d3-beb1-493fc15dd6c6","order_by":2,"name":"Paula Madrid","email":"","orcid":"","institution":"Universidad del Desarrollo","correspondingAuthor":false,"prefix":"","firstName":"Paula","middleName":"","lastName":"Madrid","suffix":""},{"id":546503125,"identity":"938f77ee-a7cd-456e-a2c4-b4d8daffcbfe","order_by":3,"name":"Michelle Salder","email":"","orcid":"","institution":"Universidad Adolfo Ibáñez","correspondingAuthor":false,"prefix":"","firstName":"Michelle","middleName":"","lastName":"Salder","suffix":""},{"id":546503126,"identity":"8080aa6f-45ca-4d57-b8c6-0d0ca928fe4f","order_by":4,"name":"Alejandra Carreño","email":"","orcid":"","institution":"Universidad del Desarrollo","correspondingAuthor":false,"prefix":"","firstName":"Alejandra","middleName":"","lastName":"Carreño","suffix":""},{"id":546503127,"identity":"990d3a79-c110-4c9b-8189-696e3373a548","order_by":5,"name":"Sofía Bowen","email":"","orcid":"","institution":"University of Chile","correspondingAuthor":false,"prefix":"","firstName":"Sofía","middleName":"","lastName":"Bowen","suffix":""},{"id":546503128,"identity":"0fab2b95-b65d-4714-903a-01dd6f56d6df","order_by":6,"name":"Alice Blukacz","email":"","orcid":"","institution":"Instituto de Investigaciones Sociales de América Latina","correspondingAuthor":false,"prefix":"","firstName":"Alice","middleName":"","lastName":"Blukacz","suffix":""}],"badges":[],"createdAt":"2025-10-15 21:23:15","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7871693/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7871693/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":96268888,"identity":"ec204c75-c6f3-4463-9647-07683fa9730d","added_by":"auto","created_at":"2025-11-19 09:08:09","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":141873,"visible":true,"origin":"","legend":"","description":"","filename":"OriginalresearchpregnantwomenBMC.docx","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/84db7dfc3600ad04a2fdc5e1.docx"},{"id":96268892,"identity":"ac90d3d2-7e3b-4a0d-acf2-40560a12f53c","added_by":"auto","created_at":"2025-11-19 09:08:09","extension":"json","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":9620,"visible":true,"origin":"","legend":"","description":"","filename":"33b763a41b9a4ff9b9f1d230b4cf677f.json","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/9bf2b705e1af2c4596f9f7a8.json"},{"id":96268897,"identity":"c90c3b8b-51e4-4009-9c74-07be64fccdf3","added_by":"auto","created_at":"2025-11-19 09:08:10","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":19874,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryfilesBMC.docx","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/e6e1ce7fee9c48ed1d8fd8dd.docx"},{"id":96268891,"identity":"d0381fca-1982-4639-a995-43be1c6890c8","added_by":"auto","created_at":"2025-11-19 09:08:09","extension":"xml","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":98034,"visible":true,"origin":"","legend":"","description":"","filename":"33b763a41b9a4ff9b9f1d230b4cf677f1enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/d59ab4ed84b3a31a40cd38b1.xml"},{"id":96268889,"identity":"af3c4492-29d5-479b-91cc-10a3d2aadc54","added_by":"auto","created_at":"2025-11-19 09:08:09","extension":"xml","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":96312,"visible":true,"origin":"","legend":"","description":"","filename":"33b763a41b9a4ff9b9f1d230b4cf677f1structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/cbf1596f0b4ca390d403553d.xml"},{"id":96268895,"identity":"ebcf027a-cf1c-4099-8d07-f654234fb162","added_by":"auto","created_at":"2025-11-19 09:08:10","extension":"html","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":107550,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/082a2c91e18a010ec3c92f62.html"},{"id":96364289,"identity":"fed20610-8704-472c-8bef-c8230c3fe44e","added_by":"auto","created_at":"2025-11-20 10:09:09","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":575044,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/4d363dbf-a9df-41b8-99f4-ecc5a5663e57.pdf"},{"id":96268887,"identity":"b18d1ac3-23f5-4beb-a376-d7634f4153f1","added_by":"auto","created_at":"2025-11-19 09:08:09","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":19874,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryfilesBMC.docx","url":"https://assets-eu.researchsquare.com/files/rs-7871693/v1/4a52ce7870999a508a88ddc6.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Perceived Barriers to Pregnancy Vaccination Plans in Chile: A Qualitative Analysis","fulltext":[{"header":"CONTRIBUTION TO THE LITERATURE","content":"\u003cul\u003e\n \u003cli\u003eThere is a paucity of qualitative research exploring the experiences and perceptions surrounding maternal vaccination in settings characterized by high immunization coverage and publicly funded vaccination programs, particularly within Latin American contexts such as Chile.\u003c/li\u003e\n \u003cli\u003eThis study offers novel empirical insights from Chile, elucidating the ways in which structural, relational, and cultural determinants shape decision-making processes regarding vaccination during pregnancy.\u003c/li\u003e\n \u003cli\u003eThe findings underscore the impact of immigration status and experiences of discrimination on both access to and trust in immunization services\u0026mdash;an area that remains insufficiently examined in countries with well-established national vaccination programs.\u003c/li\u003e\n \u003cli\u003eThese results contribute to the global discourse by emphasizing the imperative for culturally responsive and rights-based approaches to ensure equitable access to maternal vaccination.\u003c/li\u003e\n \u003cli\u003eThe findings enhance the global understanding of the necessity for culturally sensitive and rights-centred strategies to promote equitable vaccination for pregnant women.\u003c/li\u003e\n\u003c/ul\u003e"},{"header":"BACKGROUND","content":"\u003cp\u003eVaccination is widely recognized as one of the most cost-effective public health interventions. It plays a crucial role in reducing mortality and morbidity across the lifespan and in preventing and controlling outbreaks of infectious diseases (\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e). Between 2010 and 2015, it is estimated that immunization efforts helped prevent over 5\u0026nbsp;million deaths annually (\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e). In 2012, the World Health Organization (WHO) launched the Global Vaccine Action Plan with the aim of achieving and sustaining high and equitable vaccination coverage worldwide. Despite these efforts, significant disparities in vaccine access and coverage persist between high-income countries and those with middle and low incomes, as well as within these countries themselves. These inequities continue to pose a major challenge to global public health (\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e). Strengthening immunization systems is essential for achieving the Sustainable Development Goals (SDGs) (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e).\u003c/p\u003e\u003cp\u003eIn the aftermath of the pandemic, two major types of gaps in vaccination coverage have emerged. First, access to and use of SARS-CoV-2 vaccines has been highly unequal. Alarmingly, in 2022 only 11% of the total population in low-income countries received the COVID-19 vaccine (\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e). Second, the pandemic disrupted routine immunization efforts for other infectious diseases. Global coverage of national immunization programs declined from 86% in 2019 to 83% in 2020, the lowest number since 2009 (\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e). The regions most affected by these vaccination gaps include North Africa and the Middle East, South Asia, and Latin America and the Caribbean (\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e). There is the urgent need to understand the modifiable factors and mechanisms underlying vaccine inequalities, in addition to systemic challenges related to public policy, coordination, and health systems capacity to deliver vaccines (\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e). Other barriers have been identified\u0026mdash;particularly the lack of trust in vaccines among socially vulnerable populations (\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e). Vaccine hesitancy is driven by a range of factors, including misinformation, perceived risks of adverse effects (\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e), and ideological opposition to vaccination (\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e). These concerns are often amplified in communities facing social exclusion, economic hardship, or historical marginalization (\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e). A sustained focus on health equity, national government commitment to immunization goals, affordable pricing, reliable supply chains, and targeted strategies to reach unvaccinated populations are all essential components of successful immunization programs (\u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e, \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e).\u003c/p\u003e\u003cp\u003eVaccine hesitancy among pregnant women is a persistent global challenge that undermines maternal and neonatal health outcomes. Globally, pregnant individuals exhibit lower vaccine uptake compared to the general population, primarily due to concerns about vaccine safety, lack of clinical trial data, and mistrust in health systems(\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e). A 2024 systematic review highlighted that misinformation\u0026mdash;particularly via social media\u0026mdash;has exacerbated fears about infertility, miscarriage, and congenital anomalies, especially in low- and middle-income countries (\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e). In Latin America, vaccine hesitancy is influenced by political instability, limited access to reliable health information, and historical distrust in public health institutions (\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e).\u003c/p\u003e\u003cp\u003eChile, a high-income country with mixed public and private health systems, has a strong National Immunization Plan that was created in 1938. Chile\u0026rsquo;s Programa Nacional de Inmunizaciones (PNI), established in 1978, is a central component of the country\u0026rsquo;s public health strategy, offering universal and free access to vaccines for all residents, regardless of migratory or socioeconomic status(\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e). The program has achieved significant public health milestones, including the eradication of smallpox and poliomyelitis, and the control of diseases such as measles and diphtheria (\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e). One of the PNI\u0026rsquo;s key strengths lies in its high national coverage rates, supported by a robust logistical infrastructure and integration with maternal and child health services (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e). The program is also characterized by strong institutional support and a clearly defined immunization schedule (\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e17\u003c/span\u003e). Despite these strengths, the PNI faces several challenges, including inequities in access among migrant populations and residents of rural or underserved urban areas (\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e). Vaccine hesitancy has emerged as a barrier to maintaining high coverage, especially among pregnant women (\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e). Additionally, gaps in communication strategies have been reported, with some users citing inconsistent or insufficient information from healthcare providers (\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e18\u003c/span\u003e, \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e19\u003c/span\u003e).\u003c/p\u003e\u003cp\u003eAlthough maternal vaccine coverage is higher than in many neighboring countries, hesitancy persists due to complacency, misinformation, and inconsistent recommendations from healthcare providers (\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e). A qualitative review of maternal vaccine uptake in low- and middle-income countries, including Chile, emphasized the importance of health system factors such as provider trust, policy clarity, and access to antenatal care (\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e). A 2024 global synthesis identified that strong provider recommendations, culturally sensitive communication, and convenient access to vaccines are key facilitators of maternal immunization (\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e). We observed an evidence gap in knowledge related to perceived barriers to accessing vaccination among pregnant women in Chile and; hence, this unique secondary analysis of a larger study aimed to unveil experiences, barriers and facilitators to vaccination recommended by Chile\u0026rsquo;s National Immunization Program among pregnant women.\u003c/p\u003e"},{"header":"METHODS","content":"\u003cp\u003eA multiple Case Study was conducted (\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e). This is a qualitative methodological design in which the researcher explores bounded systems through in-depth data collection. Case studies involve multiple sources of information to provide a detailed description of each case. We conducted this study in three large cities in Chile, Antofagasta (north of Chile, desertic climate with high density or migrant communities), Santiago (the largest city in the country, the capital, in the central area of the country, Mediterranean climate) and Osorno (south of Chile, marine west coast climate). The context of the study is detailed in the supplementary files. This secondary analysis if part of a larger study that aimed to understand vaccination hesitancy for multiple vaccination efforts deployed in the country, including COVID-19 and the national immunization plan strategy.\u003c/p\u003e\u003cp\u003eBased on theoretical and practical grounds, as well as similar to previous international studies (\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e24\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e), the estimated initial sample size was 28. The study sample was constructed based on the priority groups defined by Chile\u0026rsquo;s National Immunization Program. We identified community leaders (n\u0026thinsp;=\u0026thinsp;12) as sample seeds and from them we continued recruitment through snowballing technique. 58 pregnant women or women with toddlers (i.e., recently pregnant) were invited to participate in the study. Given the growing proportion of international migrants living in the country (around 12% of the total population (\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e)), we also included migrant women in the sample recruitment process. Once the sample size was achieved (n\u0026thinsp;=\u0026thinsp;28, 14 Chileans and 14 international migrants), recruitment stopped. Those who declined to participate cited lack of time or interest. Field work took place between 01 January 2023 and 30 April 2024. Semi-structured interviews were held online based on a pre-defined guide and lasted for 60\u0026ndash;90 minutes. Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e describes the study\u0026acute;s sample. Semi-structured interview guide appears in supplementary files.\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eDescription of study sample\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"3\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePregnant Woman / Woman with toddlers (0\u0026ndash;18 months)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eN\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003e%\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e\u003cb\u003e28\u003c/b\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u003cb\u003e100\u003c/b\u003e\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCity\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAntofagasta\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e9\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e32%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSantiago\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e9\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e32%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eOsorno\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e10\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e36%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSex\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFemale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e28\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e100%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAge\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e19\u0026ndash;30\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e13\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e46%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e31\u0026ndash;40\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e13\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e46%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e41\u0026ndash;50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e2\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e7%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eNacionality\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003echilean\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e14\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e50%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003emigrant\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e14\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e50%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHealth System\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePublic Health System\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e21\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e75%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePrivate Health System\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e\u003cp\u003e7\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e25%\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003e Interviews were audio recorded and transcribed verbatim into a Word document and subsequently analyzed thematically, following the guiding categories outlined in the interview script, while also allowing for the emergence of new categories based on participants\u0026rsquo; narratives. Random revisions were conducted by a second research team member to over a third of transcriptions to secure quality. Selected quotes were translated to English for publication aims and double-checked by an independent team member who was fluent in academic English writing. To ensure the credibility and reliability of the study, the following rigor criteria were applied: (i) Participant triangulation: findings were triangulated across different study participants to enhance the robustness of the analysis. (ii) Reflexivity: the research team engaged in continuous discussion and reflection on preliminary findings as data collection progressed, in order to deepen thematic insights and enrich the analysis and presentation of results. Data saturation was achieved at 30 interviews for the dimensions of: general perception of the immunization plan, barriers and facilitators.\u003c/p\u003e\u003cp\u003eThis study was funded by the MSD Grant Global Health Equity Catalyst Fund. The project was approved by the Scientific Ethics Committee of the Faculty of Medicine Clinica Alemana, Universidad del Desarrollo (#2023-02).\u003c/p\u003e"},{"header":"RESULTS","content":"\u003cdiv id=\"Sec4\" class=\"Section2\"\u003e\u003ch2\u003eGeneral perceptions about the National Immunization Plan\u003c/h2\u003e\u003cp\u003eThere was consensus among interviewees that the country has a very strong immunization program. It is noted that there is broad coverage, without restrictions, with a \u0026ldquo;wide set\u0026rdquo; of vaccines available, and that the vaccination process is easily accessible and free of charge. This is further supported by the perception that Chile has an established \u0026ldquo;vaccination culture\u0026rdquo; and that people are generally \u0026ldquo;compliant\u0026rdquo; with the national immunization plan.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;I think it's easy to access vaccines in Chile. There's a super strict, controlled plan for which vaccines you should get throughout your life. And that information is readily available, and it's easy to access that vaccine\u0026rdquo; (Chilean Woman 14, Osorno, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eThe vast majority expressed that Chile has a very strong immunization program in comparison to other countries. International migrants considered that Chile\u0026rsquo;s vaccination plan is significantly more comprehensive and accessible than those in their countries of origin and other Latin American countries. Interviewees particularly highlighted the limited availability of vaccines in their home countries, often in the context of overwhelmed health systems.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;There [in Peru] almost no one has insurance, but here they do. Here they vaccinate everyone, whether Chilean or foreign, everyone, if they have to, even if you don't have a visa, even if you're illegal, it doesn't matter, we'll vaccinate you anyway, and that's good\u0026rdquo; (Migrant Woman 1, Antofagasta, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eIt is mentioned that the vaccination plan has evolved: new vaccines have been incorporated or some older ones have been \u0026ldquo;updated,\u0026rdquo; and booster doses for certain diseases have been added or increased. As part of this \u0026ldquo;updating\u0026rdquo; of components, several people mention that current vaccines cause fewer skin reactions and leave less scarring than those administered a few decades ago. In addition to the integration of new vaccines (including the COVID-19 vaccine), the administration of vaccines considered \u0026ldquo;seasonal,\u0026rdquo; such as the influenza vaccine, is perceived to have been \u0026ldquo;intensified.\u0026rdquo;\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;I believe there are more vaccines, especially because there are more influenza vaccines, which are boosters, and also Covid vaccines, so there is more monitoring (\u0026hellip;)\u0026rdquo; (Migrant Woman 5, Antofagasta, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\n\u003ch3\u003ePerceptions of the vaccination plan in pregnant women\u003c/h3\u003e\n\u003cp\u003ePositive perceptions are identified, primarily stemming from trust in the effectiveness of vaccines and the belief that they provide protection against disease. The perceived importance of vaccination is often reinforced by personal experiences\u0026mdash;or those of close acquaintances\u0026mdash;with illnesses that are now preventable through immunization. Trust in vaccines is further supported by accounts of individuals close to the respondents who did not experience adverse effects following vaccination during pregnancy.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;At no time was I afraid, let's say, about the vaccines, because I always did everything the gynecologist told me, the tests and everything, so I didn't feel like it was something that could put me or the baby at risk, because from the moment they told me it was a vaccine that I had to receive while I was pregnant, I said 'everyone does it, I mean, everyone, I'm not going to be the first,' and then talking to pregnant friends, of course, they were receiving them, they already had them and nothing had happened to them, so I was kind of calm about that\u0026rdquo; (Chilean Woman 1, Antofagasta, Private Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eIndividuals who exhibit a more passive adherence to vaccination generally perceive vaccination during pregnancy as a procedural requirement, rather than an emotionally significant experience. They tend not to associate the process with strong feelings. Conversely, those who express concerns about potential adverse effects of vaccines report experiencing fear.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;I got vaccinated without thinking too much about it. What I do remember is that throughout the vaccination process during pregnancy, I felt a bit of fear. I wasn\u0026rsquo;t sufficiently informed to understand why I was getting vaccinated. The doctor didn\u0026rsquo;t guide me much through the process. And when I started to do my own research, it was like, \u0026lsquo;What am I doing?\u0026rsquo; But I thought, \u0026lsquo;I have to do it,\u0026rsquo; and I didn\u0026rsquo;t question it much. Still, I got vaccinated during pregnancy with a lot of fear\u0026rdquo; (Chilean Woman 13, Osorno, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eAmong pregnant or recently pregnant women who identified themselves as adherent to vaccination, the vaccines most frequently mentioned were Influenza, COVID-19, and Tdap. Although the Tdap vaccine protects against diphtheria, tetanus, and pertussis, it is most commonly recalled simply as the \u0026ldquo;pertussis\u0026rdquo; or \u0026ldquo;whooping cough\u0026rdquo; vaccine. The vast majority of participants reported being unaware of the Tdap vaccine prior to pregnancy. It was primarily during prenatal care visits\u0026mdash;both in public and private healthcare settings\u0026mdash;that they learned about its existence and importance.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;I mean, if the midwife hadn't told me, I think it was in a good way, just like last time, I would have never had any idea that I had to get vaccinated against whooping cough. No... I didn't even know that whooping cough existed.\u0026rdquo; (Migrant Woman 8, Santiago, Public Health System)\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eCases in which women reported not having been vaccinated during pregnancy correspond to those who initiated antenatal care late or were in transit between countries during their pregnancy. The vast majority mentioned public or private health centers or vaccination clinics, with one reference to mobile health campaigns in Antofagasta.\u003c/p\u003e\n\u003ch3\u003eBarriers, facilitators and recommendations for improvement\u003c/h3\u003e\n\u003cp\u003eParticipants mentioned five types of barriers to accessing vaccination in Chile. First, they referred to problems related to vaccine information. The public health system is perceived as delivering incomplete information, with a sense that there is no interest in providing information. In contrast, the private healthcare system is generally trusted to provide all the necessary information.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;If it's not through your gynecologist, I think that if... There is no other area, or there is no other channel that informs you that you have to get the vaccine (...) I have not seen other channels, other than, if it is a person who is interested and to look it up through the Ministry, or to look for the calendar, but I don't know if the entire population is very attentive to vaccines and when each person's turn comes\u0026rdquo; (Chilean Woman 5, Santiago, Private Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eSecond, barriers related to potential adverse effects were identified as a barrier to attending prenatal health check-ups. Third, some women reported negative experiences and reported some cases of disrespectful or neglectful treatment when attending to antenatal controls.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;It has happened to me that they see you and everything is quick and then they weigh you, measure you and everything. It's like you feel vulnerable. Well, that's how I felt when I went to the doctor's office and I felt like that, like... I didn't like how they treated me. It's like they push you around... You know, we're people, but they don't see that... Because, yes, they have more education, they have studies, but they should be humbler. Especially with pregnant women, who are more, uh... prone to crying, we get more sentimental... But they don't care about that\" (Chilean Woman 8, Santiago, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eThe fourth perceived barrier to accessing vaccination plans are related to social vulnerability and lack of social support. Economic constraints were identified as a barrier to attending health check-ups, along with the lack of support networks for childcare and the inability to take time off work. The fifth and final barrier had to do with participants reporting unique barriers faced by migrant women in the country, mostly related to (i) lack of familiarity with the Chilean healthcare system, (ii) limited information about vaccines administered in the country of origin or during transit, (iii) delayed initiation of antenatal care, (iv) administrative barriers to accessing healthcare services, (v) experiences of discrimination and xenophobia, and (vi) transitions to the private healthcare system in search of respectful treatment\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;When I was pregnant, it depended on the person I was assigned to see whether I was treated. Sometimes they would see me, but other times I would get a person who would say no, ask for my papers, and put up a thousand obstacles to not accepting me while I was pregnant, feeling unwell (\u0026hellip;)\u0026rdquo; (Migrant Woman 7, Santiago, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eFacilitators of vaccination access in Chile, as reported by participants, include timely and comprehensive access to information, free provision of vaccines, and preferential care at health centers. The availability of vaccines was particularly emphasized by women. Additional facilitators include workplace permissions and accommodations, with some participants affirming that \u0026ldquo;vaccination is a right.\u0026rdquo; For migrant women included in this study, universal access to healthcare\u0026mdash;without the need for a provisional national ID number (RUT)\u0026mdash;was highlighted as a key enabler of vaccination during pregnancy.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\"The speed, the attention, and the availability of vaccines. There are times when other places don't have them, but here I really can't complain, because during my pregnancy, all the vaccines were available. You arrive, get the number, and they'll see you immediately.\" (Migrant Woman 7, Santiago, Public Health System)\u003c/em\u003e\u003c/p\u003e\u003cp\u003e\u003cem\u003e\u0026ldquo;I arrived pregnant, I registered, and they already gave me my RUT number. But even before they gave me my RUT number, they had already seen me because it was due to the pregnancy (\u0026hellip;)\u0026rdquo; (Migrant Woman 9, Santiago, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003e Finally, three main recommendations appeared from participants: (i) to strengthen access to quality and timely information about the vaccination plan in Chile, especially during pregnancy, (ii) improve patient-provider interactions and communication and the way pregnant women are treated, and (ii) train healthcare workers about health rights of migrant pregnant women in the country, including translated information packs for this population residing in the country.\u003cdiv class=\"BlockQuote\"\u003e\u003cp\u003e\u003cem\u003e\"I think for pregnant women, more information, because I had no idea what I could access or what my health rights were. And for those of us who have breastfeeding children and are pregnant, I insist on having information in other languages, like Creole for Haitians\" (Migrant Woman 8, Santiago, Public Health System).\u003c/em\u003e\u003c/p\u003e\u003c/div\u003e\u003c/p\u003e"},{"header":"DISCUSSION","content":"\u003cp\u003eOur study aimed to unravel experiences and perceptions from the perspective of pregnant women, both Chileans and international migrants, about vaccination schemes during pregnancy in Chile. Our findings suggest that there is an established vaccination culture and that people are generally compliant with the national immunization plan. We also found a number of perceived barriers and facilitators to accessing vaccines, which are from the provider and the demand sides, as well as the interaction between the two parts. Our findings are consistent with the international evidence. Low compliance with maternal vaccination schedules remains a significant public health concern both globally and in Latin America. Research indicates that vaccine hesitancy\u0026mdash;often rooted in misinformation, fear of adverse effects, and concerns about fetal safety\u0026mdash;is a primary barrier to uptake among pregnant women (\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e, \u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e). These fears are frequently exacerbated by limited access to reliable health information, particularly in underserved populations such as migrants and rural communities (\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e). In Latin America, structural challenges including fragmented health systems, inconsistent communication from healthcare providers, and logistical barriers to accessing prenatal care further hinder vaccination adherence (\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e). Socioeconomic factors, such as unstable employment, lack of childcare support, and transportation difficulties, also contribute to missed opportunities for immunization (\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e). Addressing these multifaceted barriers requires integrated strategies that combine culturally sensitive education, improved provider-patient communication, and systemic reforms to ensure equitable access to maternal vaccines.\u003c/p\u003e\u003cp\u003eThis study contributes to existing public health research and policy. In Chile, qualitative research on vaccine hesitancy among pregnant women remains limited, despite growing global evidence highlighting the complexity of maternal decision-making regarding immunization (\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e). However, in the Chilean context, there is a notable gap in understanding how factors like migration status and regional disparities shape vaccine perceptions and behaviors during pregnancy (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e). Addressing these gaps requires investment in locally grounded, interdisciplinary research that engages pregnant women as co-creators of knowledge and policy solutions. Policy implications of this study are related to the lack of culturally and contextually grounded research calls for the integration of participatory approaches in health policy design, ensuring that interventions reflect the lived experiences of diverse populations, including indigenous and migrant women (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e). Also, policies should strengthen the role of primary care providers as trusted sources of vaccine information, supported by training in culturally sensitive communication and shared decision-making (\u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e).\u003c/p\u003e\u003cp\u003eThis qualitative study offers valuable insights into the complex and context-specific factors influencing pregnant women's hesitancy toward vaccination, particularly by capturing personal narratives, cultural beliefs, and emotional responses that quantitative methods may overlook. Through in-depth interviews and thematic analyses, we could explore nuanced perceptions of risk and trust in healthcare systems (\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e). However, this study has a relatively small sample size, facing limitations in generalizability and may not adequately represent the diversity of experiences across different socioeconomic, ethnic, or geographic groups of pregnant women that reside in the three cities included in this study (\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e). Additionally, findings may be influenced by selection bias, as these women were recruited through snowballing technique. Despite these constraints, this qualitative study shed light on current understanding of vaccination perceptions and barriers among pregnant women in Chile, hence remaining essential for hypothesis generation and for informing culturally sensitive interventions, especially in under-researched populations (\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e). Moreover, this analysis fills a gap in the pressing need for qualitative research that incorporates the voice of pregnant women, especially among some marginalized groups such as migrants, who often face compounded barriers to vaccine access and acceptance (\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e). Future research should prioritize longitudinal designs, participatory methodologies, and culturally tailored interventions to better inform practice and policy.\u003c/p\u003e"},{"header":"CONCLUSIONS","content":"\u003cp\u003eThis study demonstrates that, despite widespread recognition of Chile\u0026rsquo;s immunization program as robust and internationally acclaimed, a closer examination of maternal vaccination reveals persistent barriers and challenges in access. Although the national system offers broad coverage, free provision, and nominal accessibility, low adherence among pregnant women is primarily driven by structural and relational factors. These include insufficient and untimely information, concerns about adverse effects, inadequate interpersonal treatment within healthcare settings, and socioeconomic vulnerability. For migrant women, additional barriers emerge, such as limited knowledge of the healthcare system, administrative obstacles, experiences of discrimination, and delayed initiation of prenatal care. Nevertheless, the policy of universal access to vaccination\u0026mdash;without requiring a tax identification number\u0026mdash;serves as a significant facilitator.\u003c/p\u003e\u003cp\u003eOur findings highlight the urgent need for structural reforms and integrated strategies aimed at enhancing information dissemination, strengthening communication between healthcare providers and users, and fostering culturally sensitive care. This research provides critical qualitative evidence to inform the development of more equitable and inclusive maternal vaccination policies.\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cdiv class=\"DefinitionList\"\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eWHO\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eWorld Health Organization\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eSDGs\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eSustainable Development Goals\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003ePNI\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eChile\u0026acute;s National Immunization Plan\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"DefinitionListEntry\"\u003e\u003cdiv class=\"Term\"\u003eTdap\u003c/div\u003e\u003cdiv class=\"Description\"\u003e\u003cp\u003eDiphtheria, Tetanus, and Pertussis Vaccine\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eEthics approval and consent to participate\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was conducted in accordance with the appropriate guidelines and regulations for research involving human beings, including the Declaration of Helsinki. It received approval from the Scientific Ethics Committee at Universidad del Desarrollo (#2023-02) before its execution. All participants read and signed an online informed consent. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eNot applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and materials\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe data supporting this study\u0026apos;s findings are available on request from the corresponding author, A.O. \u0026nbsp;However, the data are not publicly available due to participants confidentiality.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompeting interests\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no competing interests. The entire study was conducted independently by the research team at UDD.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was funded by MSD Equity grant, which has applied to and granted by an external reviewing committee.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthor contributions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAll authors contributed to the investigation, validation, visualization, and editing of the manuscript. Authors BC, AO, and AC were responsible for the conceptualization. Authors BC, AO, MS, and AB contributed to the methodology. Formal analysis was conducted by Authors BC, AO, and MS, while data curation was managed by Authors AO, PM, MS, and SB. Project administration was overseen by Authors BC, AO, PM, AC, and SB, with supervision provided by Authors BC, AO, AC, and SB. Funding acquisition and resource management were handled by Authors BC and AO, and the original draft was prepared by Authors BC, AO, and PM.I certify that this manuscript represents an original work and that it, or another work with substantially similar content by me, has not been published, in parts or completely, nor is it being considered for publication by another journal, be it in print or digital publications.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eWe acknowledge all study participants for their time and generosity.\u003c/p\u003e\n\u003cp\u003eThe final version of the manuscript went through final grammar revision and editing in Grammarly software.\u0026nbsp;\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eWorld Health Assembly. Global vaccine action plan. Geneva; 2012.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePatel MK, Goodson JL, Alexander JP, Kretsinger K, Sodha SV, Steulet C, et al. Progress Toward Regional Measles Elimination \u0026mdash; Worldwide, 2000\u0026ndash;2019. MMWR Morb Mortal Wkly Rep. 2020;69(45):1700\u0026ndash;5.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eGavi.The Vaccine Alliance. Immunisation and the Sustainable Development Goals. 2024.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eUnited Nations. Transforming our world: the 2030 Agenda for Sustainable Development [Internet]. New York. 2015. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://sdgs.un.org/publications/transforming-our-world-2030-agenda-sustainable-development-17981\u003c/span\u003e\u003cspan address=\"https://sdgs.un.org/publications/transforming-our-world-2030-agenda-sustainable-development-17981\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWorld Health Organization. Strategy to Achieve Global Covid-19 Vaccination by mid-2022 [Internet], Washington DC. 2022. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf?sfvrsn=5a68433c_5\u003c/span\u003e\u003cspan address=\"https://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf?sfvrsn=5a68433c_5\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWorld Health Organization, Accelerating. COVID-19 Vaccine Deployment Removing obstacles to increase coverage levels and protect those at high risk [Internet]. Washington DC; 2022 Mar. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.who.int/publications/m/item/accelerating-covid-19-vaccine-deployment\u003c/span\u003e\u003cspan address=\"https://www.who.int/publications/m/item/accelerating-covid-19-vaccine-deployment\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWorld Health Organization. Routine immunization services during the COVID-19 pandemic [Internet]. Geneva. 2020. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://apps.who.int/iris/handle/10665/331925\u003c/span\u003e\u003cspan address=\"https://apps.who.int/iris/handle/10665/331925\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eUNICEF. COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows [Internet]. Genova/ New York; 2021. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.unicef.org/press-releases/covid-19-pandemic-leads-major-backsliding-childhood-vaccinations-new-who-unicef-data#:~:text=GENEVA%2FNEW%20YORK%2C%2015%20July,today%20by%20WHO%20and%20UNICEF\u003c/span\u003e\u003cspan address=\"https://www.unicef.org/press-releases/covid-19-pandemic-leads-major-backsliding-childhood-vaccinations-new-who-unicef-data#:~:text=GENEVA%2FNEW%20YORK%2C%2015%20July,today%20by%20WHO%20and%20UNICEF\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWorld Health Organization. Progress and challenges with achieving universal immunization coverage [Internet]. Genova. 2025. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.who.int/publications/m/item/progress-and-challenges\u003c/span\u003e\u003cspan address=\"https://www.who.int/publications/m/item/progress-and-challenges\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eGoje O, Kapoor A. Meeting the challenge of vaccine hesitancy. Cleve Clin J Med. 2024;91(9 suppl 1):S50\u0026ndash;6.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKim Y, Iachan R, Boyle J, Deng Y. Association Between County-Level Social Vulnerability and Vaccine-Related Attitudes and Hesitancy Toward COVID-19 Vaccination in the United States. Vaccines (Basel). 2024;12(12):1368.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eUNICEF. Immunization Supply Chain Interventions to Enable Coverage and Equity in Urban Poor, Remote Rural and Conflict Settings [Internet]. New York. 2020. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.unicef.org/media/96611/file/Immunization%20supply%20chain%20interventions.pdf\u003c/span\u003e\u003cspan address=\"https://www.unicef.org/media/96611/file/Immunization%20supply%20chain%20interventions.pdf\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCasubhoy I, Kretz A, Tan HL, St Clair LA, Parish M, Golding H, et al. A scoping review of global COVID-19 vaccine hesitancy among pregnant persons. NPJ Vaccines. 2024;9(1):131.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKennedy SH, MacDonald NE, Costa Clemens SA. Vaccination in pregnancy. Front Glob Womens Health. 2025;5.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eGon\u0026ccedil;alves BA, Matos CC, de Ferreira SA, Itagyba JV, Mo\u0026ccedil;o RF, Couto VR. MT. Hesita\u0026ccedil;\u0026atilde;o vacinal contra a COVID-19 na Am\u0026eacute;rica Latina e \u0026Aacute;frica: uma revis\u0026atilde;o de escopo. Cad Saude Publica. 2023;39(8).\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eDepartamento de vacunas e inmunizaciones. Ministerio de Salud de Chile. [cited 2025 Aug 7]. Vacunas. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://vacunas.minsal.cl/\u003c/span\u003e\u003cspan address=\"https://vacunas.minsal.cl/\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMinisterio de Salud. ESTRATEGIA, NACIONAL DE SALUD PARA LOS OBJETIVOS, SANITARIOS AL 2030 [Internet]. 2022. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.fao.org/faolex/results/details/en/c/LEX-FAOC223969\u003c/span\u003e\u003cspan address=\"https://www.fao.org/faolex/results/details/en/c/LEX-FAOC223969\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOECD. OECD Reviews of Public Health: Chile [Internet]. OECD. 2019. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.oecd.org/content/dam/oecd/en/publications/reports/2019/01/oecd-reviews-of-public-health-chile_g1g9a372/9789264309593-en.pdf\u003c/span\u003e\u003cspan address=\"https://www.oecd.org/content/dam/oecd/en/publications/reports/2019/01/oecd-reviews-of-public-health-chile_g1g9a372/9789264309593-en.pdf\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eAlianza del Centro de Estudios Justicia y Sociedad de la Pontificia Universidad Cat\u0026oacute;lica de Chile, Fundaci\u0026oacute;n, Colunga W, Chile UNICEF, Chile. Estudio exploratorio de caracterizaci\u0026oacute;n de ni\u0026ntilde;os, ni\u0026ntilde;as y adolescentes migrantes de Am\u0026eacute;rica Latina y el Caribe y sus familias en Chile [Internet]. Santiago; 2020 Oct. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.unicef.org/chile/media/4476/file/Informe.pdf\u003c/span\u003e\u003cspan address=\"https://www.unicef.org/chile/media/4476/file/Informe.pdf\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eRazai MS, Mansour R, Ravindran P, Freeman S, Mason-Apps C, Morris J, et al. Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review. PLoS ONE. 2024;19(4):e0298407.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eDavies B, Olivier J, Amponsah-Dacosta E. Health Systems Determinants of Delivery and Uptake of Maternal Vaccines in Low- and Middle-Income Countries: A Qualitative Systematic Review. Vaccines (Basel). 2023;11(4):869.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBhattacharya O, Siddiquea BN, Shetty A, Afroz A, Billah B. COVID-19 vaccine hesitancy among pregnant women: a systematic review and meta-analysis. BMJ Open. 2022;12(8):e061477.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eYin RK. Case Study Research and Applications: Design and Methods. 6th ed. SAGE; 2017.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBerendes S, Mounier-Jack S, Ojo-Aromokudu O, Ivory A, Tucker JD, Larson HJ, et al. Figuring stuff out myself \u0026ndash; a qualitative study on maternal vaccination in socially and ethnically diverse areas in England. BMC Public Health. 2023;23(1):1408.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCox E, Sanchez M, Baxter C, Crary I, Every E, Munson J, et al. COVID-19 Vaccine Hesitancy among English-Speaking Pregnant Women Living in Rural Western United States. Vaccines (Basel). 2023;11(6):1108.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eServicio Nacional de Migraciones (SERMIG). Gobierno de Chile. 2025 [cited 2025 Aug 7]. Estimaciones de extranjeros residentes en Chile al 31 de diciembre de 2024. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://serviciomigraciones.cl/estudios-migratorios/estimaciones-de-extranjeros/\u003c/span\u003e\u003cspan address=\"https://serviciomigraciones.cl/estudios-migratorios/estimaciones-de-extranjeros/\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKilich E, Dada S, Francis MR, Tazare J, Chico RM, Paterson P, et al. Factors that influence vaccination decision-making among pregnant women: A systematic review and meta-analysis. PLoS ONE. 2020;15(7):e0234827.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161\u0026ndash;4.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eRodriguez-Morales AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, Escalera-Antezana JP, Alvarado-Arnez LE, et al. Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama. Travel Med Infect Dis. 2025;65:102839.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePan American Health Organization. Maternal immunization in Latin America and the Caribbean: A review of current practices and challenges. Washington, DC; 2022.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLarson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007\u0026ndash;2012. Vaccine. 2014;32(19):2150\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eRazai MS, Ussher M, Goldsmith L, Hargreaves S, Oakeshott P. Navigating vaccination in pregnancy: Qualitative study in 21 ethnically diverse pregnant women. PLoS ONE. 2025;20(1):e0310823.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eNu\u0026ntilde;ez-Franz L, Rubilar P, Apablaza M, Canales L, Cort\u0026eacute;s LJ, Molina X, et al. Population-based seroprevalence survey: post-pandemic COVID-19 vaccination, related factors, and geographic distribution of vaccine acceptability in Chile. BMC Public Health. 2025;25(1):1176.\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eTroncoso-Espinoza PV, Figueroa-Lassalle CF. Hacia una atenci\u0026oacute;n de calidad integral en las maternidades con perspectiva de derechos humanos. Rev Chil Obstet Ginecol. 2022;87(2).\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMendez I, Gilliard VG, Randall LA, Robertson A. Attitudes and Experiences Regarding Communication About Maternal Vaccination: Qualitative Findings from Non-Hispanic Black Pregnant People. J Womens Health. 2025;34(1):1\u0026ndash;7.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"archives-of-public-health","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"aoph","sideBox":"Learn more about [Archives of Public Health](http://archpublichealth.biomedcentral.com/)","snPcode":"13690","submissionUrl":"https://submission.nature.com/new-submission/13690/3","title":"Archives of Public Health","twitterHandle":"@Archpubhealth","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Vaccination, Pregnant Women, Emigrants and immigrants, Qualitative Research, Chile, Health Care Quality, Access, and Evaluation","lastPublishedDoi":"10.21203/rs.3.rs-7871693/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7871693/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003eBackground\u003c/h2\u003e\u003cp\u003eVaccination is widely recognized as a cost-effective public health intervention. However, vaccination rates among pregnant women have been decreasing, especially in low and middle-income countries and in subgroups like migrant communities. Hence, the purpose of this study was to unveil experiences, barriers and facilitators to vaccination recommended by Chile\u0026rsquo;s National Immunization Program among pregnant women, both locals and international migrants, in three large cities in Chile.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e\u003cp\u003eA multiple Case Study was conducted. Through snowballing technique, local and migrant pregnant women or women with toddlers (i.e., recently pregnant) were invited to participate (n\u0026thinsp;=\u0026thinsp;28, 14 Chileans and 14 international migrants). Semi-structured interviews were held online based on a pre-defined guide and lasted for 60\u0026ndash;90 minutes. Interviews were audio recorded and transcribed verbatim and analyzed thematically. The project was approved by the Scientific Ethics Committee at UDD.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e\u003cp\u003eThere was general consensus that the country has a very strong immunization program, along with a well-established vaccination culture and compliance with the national immunization plan. Participants identified five main barriers to access vaccines: (i) problems related to vaccine information, (ii) barriers related to potential adverse effects, (iii) some cases of disrespectful or neglectful treatment, (iv) social vulnerability and lack of social support, and (v) unique barriers faced by migrant women. Perceived facilitators were the following three: (i) timely and comprehensive access to information, (ii) free provision of vaccines, and (iii) preferential care at health centers.\u003c/p\u003e\u003ch2\u003eConclusions\u003c/h2\u003e\u003cp\u003eFindings highlight the need for strengthening access to quality and timely information about the vaccination plan during pregnancy, improving client-provider communication, ensuring dignified treatment, and training healthcare workers about health rights of migrant pregnant women in the country. Addressing these multifaceted barriers requires integrated strategies that combine culturally sensitive education, improved provider-patient interactions, and systemic reforms to ensure equitable, non-discriminatory access to maternal vaccines.\u003c/p\u003e","manuscriptTitle":"Perceived Barriers to Pregnancy Vaccination Plans in Chile: A Qualitative Analysis","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-11-19 09:08:04","doi":"10.21203/rs.3.rs-7871693/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2025-12-15T08:23:59+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-12-14T19:56:39+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2025-11-27T05:14:43+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"273190287980898989811871072105555942560","date":"2025-11-27T01:54:24+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"237090694707438889282078349407911028692","date":"2025-11-19T11:48:58+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2025-11-10T08:11:45+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2025-11-01T10:26:13+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2025-11-01T10:25:26+00:00","index":"","fulltext":""},{"type":"submitted","content":"Archives of Public Health","date":"2025-10-15T21:15:14+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"archives-of-public-health","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"aoph","sideBox":"Learn more about [Archives of Public Health](http://archpublichealth.biomedcentral.com/)","snPcode":"13690","submissionUrl":"https://submission.nature.com/new-submission/13690/3","title":"Archives of Public Health","twitterHandle":"@Archpubhealth","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"em","reportingPortfolio":"BMC/SO AJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"1ec435b0-febc-48ac-938c-a6827d913053","owner":[],"postedDate":"November 19th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[],"tags":[],"updatedAt":"2026-05-02T09:09:57+00:00","versionOfRecord":[],"versionCreatedAt":"2025-11-19 09:08:04","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7871693","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7871693","identity":"rs-7871693","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}